Machine Learning for Discovery of Translatable Targets and Biomarkers - Keynote

Watch a keynote address from the Broad Institute Machine Learning in Drug Discovery Symposium 2023 featuring Daphne Koller, CEO and Founder of Insitro. Explore the application of machine learning in discovering translatable targets and biomarkers for drug development. Gain insights into cutting-edge approaches that combine artificial intelligence with biological research to accelerate the drug discovery process. Learn how these innovative techniques are revolutionizing the identification of potential therapeutic targets and biomarkers, potentially leading to more efficient and effective drug development strategies. This 51-minute presentation offers a comprehensive overview of the intersection between machine learning and pharmaceutical research, delivered by a leading expert in the field.

Broad Institute Machine Learning in Drug Discovery Symposium 2023: Keynote - Daphne Koller